Hong-Jen Chang, former Deputy Minister of Health and current CEO and Chairman of the YFY Biotech Management Company, a Taiwan-based VC fund which has been playing an instrumental role in the development of Taiwan’s biotech industry, provides insights into his investment approach and documents the key success factors to prioritize for the future development of local, innovation-driven biotech companies, as well as the contribution of YFY to further propel the local biotech eco-system.
As former Deputy Minister of Health of Taiwan and former President of the National Health Insurance Administration (NHIA, formerly known as BNHI), what do you see as the key milestones that have contributed to the strengthening of Taiwan’s health system?
"When I joined YFY, I didn’t have any experience in the investment industry and my first priority was then to build the team that would allow us to thrive."
